Jayson Bedford
Stock Analyst at Raymond James
(3.85)
# 752
Out of 4,413 analysts
196
Total ratings
53.82%
Success rate
6.9%
Average return
Main Sectors:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Maintains: Strong Buy | $151 → $160 | $125.88 | +27.11% | 20 | Apr 26, 2024 | |
| BSX Boston Scientific | Maintains: Strong Buy | $73 → $85 | $72.21 | +17.71% | 15 | Apr 25, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $84 → $89 | $76.63 | +16.14% | 16 | Jan 30, 2024 | |
| ABT Abbott Laboratories | Maintains: Outperform | $124 → $127 | $106.29 | +19.48% | 21 | Jan 25, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $372 → $435 | $371.70 | +17.03% | 6 | Jan 25, 2024 | |
| ANGO AngioDynamics | Maintains: Outperform | $12 → $10 | $5.79 | +72.71% | 8 | Jan 9, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $133 → $137 | $119.56 | +14.59% | 4 | Jan 3, 2024 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $172 → $175 | $151.18 | +15.76% | 16 | Jan 3, 2024 | |
| BDX Becton, Dickinson and Company | Maintains: Outperform | $269 → $275 | $233.72 | +17.66% | 2 | Jan 3, 2024 | |
| TFX Teleflex | Maintains: Outperform | $227 → $271 | $211.54 | +28.11% | 12 | Dec 20, 2023 | |
| BWAY BrainsWay | Downgrades: Market Perform | n/a | $5.56 | - | 7 | Nov 16, 2023 | |
| MASI Masimo | Downgrades: Market Perform | n/a | $134.01 | - | 4 | Nov 8, 2023 | |
| PODD Insulet | Maintains: Outperform | $299 → $228 | $170.27 | +33.90% | 13 | Sep 15, 2023 | |
| TNDM Tandem Diabetes Care | Downgrades: Market Perform | n/a | $36.20 | - | 9 | Apr 24, 2023 | |
| EW Edwards Lifesciences | Downgrades: Market Perform | n/a | $84.30 | - | 13 | Feb 6, 2023 | |
| BAX Baxter International | Downgrades: Market Perform | n/a | $40.34 | - | 6 | Jan 5, 2023 | |
| ICUI ICU Medical | Downgrades: Market Perform | n/a | $98.29 | - | 9 | Nov 8, 2022 | |
| MDT Medtronic | Downgrades: Market Perform | n/a | $80.89 | - | 8 | Aug 24, 2022 | |
| SENS Senseonics Holdings | Downgrades: Underperform | n/a | $0.46 | - | 2 | Mar 5, 2021 | |
| HOLX Hologic | Upgrades: Outperform | n/a | $76.28 | - | 1 | Jun 3, 2020 | |
| BEAT HeartBeam | Maintains: Outperform | n/a | $2.16 | - | 2 | Oct 31, 2018 | |
| IART Integra LifeSciences Holdings | Downgrades: Market Perform | n/a | $29.18 | - | 2 | Jan 2, 2018 |
DexCom
Apr 26, 2024
Maintains: Strong Buy
Price Target: $151 → $160
Current: $125.88
Upside: +27.11%
Boston Scientific
Apr 25, 2024
Maintains: Strong Buy
Price Target: $73 → $85
Current: $72.21
Upside: +17.71%
Merit Medical Systems
Jan 30, 2024
Maintains: Outperform
Price Target: $84 → $89
Current: $76.63
Upside: +16.14%
Abbott Laboratories
Jan 25, 2024
Maintains: Outperform
Price Target: $124 → $127
Current: $106.29
Upside: +19.48%
Intuitive Surgical
Jan 25, 2024
Maintains: Outperform
Price Target: $372 → $435
Current: $371.70
Upside: +17.03%
AngioDynamics
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $5.79
Upside: +72.71%
Zimmer Biomet Holdings
Jan 3, 2024
Maintains: Outperform
Price Target: $133 → $137
Current: $119.56
Upside: +14.59%
Johnson & Johnson
Jan 3, 2024
Maintains: Outperform
Price Target: $172 → $175
Current: $151.18
Upside: +15.76%
Becton, Dickinson and Company
Jan 3, 2024
Maintains: Outperform
Price Target: $269 → $275
Current: $233.72
Upside: +17.66%
Teleflex
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $211.54
Upside: +28.11%
BrainsWay
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.56
Upside: -
Masimo
Nov 8, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $134.01
Upside: -
Insulet
Sep 15, 2023
Maintains: Outperform
Price Target: $299 → $228
Current: $170.27
Upside: +33.90%
Tandem Diabetes Care
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $36.20
Upside: -
Edwards Lifesciences
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $84.30
Upside: -
Baxter International
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $40.34
Upside: -
ICU Medical
Nov 8, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $98.29
Upside: -
Medtronic
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $80.89
Upside: -
Senseonics Holdings
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.46
Upside: -
Hologic
Jun 3, 2020
Upgrades: Outperform
Price Target: n/a
Current: $76.28
Upside: -
HeartBeam
Oct 31, 2018
Maintains: Outperform
Price Target: n/a
Current: $2.16
Upside: -
Integra LifeSciences Holdings
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $29.18
Upside: -